Hong Fok Corporation Limited (SGX:H30)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	651	672	746	778	642	625
Market Cap Growth	-9.89%	-9.89%	-4.22%	21.26%	2.70%	16.09%
Enterprise Value	1,880	1,926	1,994	2,067	1,973	2,014
Last Close Price	0.80	0.81	0.89	0.92	0.73	0.70
PE Ratio	21.49	28.29	8.47	3.54	16.50	-
PS Ratio	6.24	6.44	6.74	5.06	7.09	7.77
PB Ratio	0.22	0.23	0.26	0.28	0.25	0.24
P/OCF Ratio	13.01	13.42	13.68	7.67	13.02	23.75
EV/Sales Ratio	18.02	18.46	18.03	13.43	21.79	25.04
EV/EBITDA Ratio	44.25	45.69	37.90	27.84	51.63	51.32
EV/EBIT Ratio	45.09	46.19	38.34	28.22	52.96	52.56
Debt / Equity Ratio	0.23	0.23	0.25	0.25	0.29	0.31
Debt / EBITDA Ratio	15.52	15.52	13.45	9.39	19.69	19.51
Asset Turnover	0.03	0.03	0.03	0.04	0.03	0.02
Inventory Turnover	0.31	0.31	0.28	0.39	0.20	0.13
Quick Ratio	1.05	1.05	1.73	1.08	0.57	1.05
Current Ratio	3.33	3.33	4.06	3.59	1.50	3.74
Return on Equity (ROE)	0.49%	0.49%	3.33%	8.61%	1.72%	-1.01%
Return on Assets (ROA)	0.71%	0.71%	0.90%	1.30%	0.68%	0.69%
Return on Capital (ROIC)	0.72%	0.72%	0.91%	1.33%	0.69%	0.71%
Earnings Yield	3.65%	3.53%	11.81%	28.27%	6.06%	-1.39%
Dividend Yield	1.23%	1.24%	1.13%	1.09%	1.38%	1.43%
Payout Ratio	27.03%	27.03%	7.29%	2.98%	17.15%	-
Buyback Yield / Dilution	0.01%	0.01%	1.70%	2.13%	0.83%	1.82%
Total Shareholder Return	1.24%	1.24%	2.83%	3.22%	2.21%	3.26%

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.